North America In-Vitro Diagnostics Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America In-Vitro Diagnostics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America In-Vitro Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising incidence of chronic diseases
5.1.2 Demand for early diagnostic tools

5.2 Market Opportunities

5.2.1 Growth in point-of-care diagnostic testing
5.2.2 Expansion into emerging healthcare markets

5.3 Future Trends

5.3.1 Adoption of molecular diagnostics
5.3.2 Advancements in lab automation

5.4 Impact of Drivers and Restraints

6. North America In-Vitro Diagnostics Market Regional Analysis

6.1 North America In-Vitro Diagnostics Market Overview

6.2 North America In-Vitro Diagnostics Market Revenue 2020-2030 (US$ Million)

6.3 North America In-Vitro Diagnostics Market Forecast Analysis

7. North America In-Vitro Diagnostics Market Analysis – by Product & Services

7.1 Reagents & Kits

7.1.1 Overview
7.1.2 Reagents & Kits: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Instruments

7.2.1 Overview
7.2.2 Instruments: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Software & Services

7.3.1 Overview
7.3.2 Software & Services: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. North America In-Vitro Diagnostics Market Analysis – by Technology

8.1 Immunoassay/Immunochemistry

8.1.1 Overview
8.1.2 Immunoassay/Immunochemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Clinical Chemistry

8.2.1 Overview
8.2.2 Clinical Chemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Molecular Diagnostics

8.3.1 Overview
8.3.2 Molecular Diagnostics: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Microbiology

8.4.1 Overview
8.4.2 Microbiology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.5 Blood Glucose Self-Monitoring

8.5.1 Overview
8.5.2 Blood Glucose Self-Monitoring: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.6 Coagulation & Hemostasis

8.6.1 Overview
8.6.2 Coagulation & Hemostasis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.7 Hematology

8.7.1 Overview
8.7.2 Hematology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.8 Urinalysis

8.8.1 Overview
8.8.2 Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9. North America In-Vitro Diagnostics Market Analysis – by Application

9.1 Infectious Diseases

9.1.1 Overview
9.1.2 Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Diabetes

9.2.1 Overview
9.2.2 Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Oncology

9.3.1 Overview
9.3.2 Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.4 Cardiology

9.4.1 Overview
9.4.2 Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.5 Autoimmune Diseases

9.5.1 Overview
9.5.2 Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.6 Nephrology

9.6.1 Overview
9.6.2 Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10. North America In-Vitro Diagnostics Market – North America Analysis

10.1 North America

10.1.1 North America In-Vitro Diagnostics Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 North America In-Vitro Diagnostics Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 US: North America In-Vitro Diagnostics Market Breakdown, by Product & Services
10.1.1.1.2 US: North America In-Vitro Diagnostics Market Breakdown, by Technology
10.1.1.1.3 US: North America In-Vitro Diagnostics Market Breakdown, by Application

10.1.1.2 Canada: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Canada: North America In-Vitro Diagnostics Market Breakdown, by Product & Services
10.1.1.2.2 Canada: North America In-Vitro Diagnostics Market Breakdown, by Technology
10.1.1.2.3 Canada: North America In-Vitro Diagnostics Market Breakdown, by Application

10.1.1.3 Mexico : North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Mexico : North America In-Vitro Diagnostics Market Breakdown, by Product & Services
10.1.1.3.2 Mexico : North America In-Vitro Diagnostics Market Breakdown, by Technology
10.1.1.3.3 Mexico : North America In-Vitro Diagnostics Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America In-Vitro Diagnostics Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Becton Dickinson and Co

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 bioMerieux SA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Bio-Rad Laboratories Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Danaher Corp

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 F. Hoffmann-La Roche Ltd

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Qiagen NV

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Siemens AG

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Sysmex Corp

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Thermo Fisher Scientific Inc

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights